Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 18, 2026 14:11 ET | Source: Robbins LLP

Stockholders Who Lost Money Investing in Mereo BioPharma Group plc Should Contact Robbins LLP for Information About Recovering Their Losses from MREO

Robbins LLP is Investigating Allegations that Mereo BioPharma Group plc (MREO) Misled Investors Regarding Phase 3 Orbit and Cosmic Studies for Setrusumab
February 18, 2026 14:07 ET | Source: Robbins LLP

Stockholders Who Lost Money Investing in Ultragenyx Pharmaceutical Inc. Should Contact Robbins LLP for Information About Recovering Their Losses from RARE

Robbins LLP is Investigating Allegations that Ultragenyx Pharmaceutical Inc. (RARE) Misled Investors Regarding Phase III Orbit and Cosmic Studies
February 18, 2026 14:03 ET | Source: Robbins LLP

Ramaco Resources, Inc. Shareholders Who Lost Money Investing in METC Should Contact Robbins LLP for Information About Recovering Their Losses

Robbins LLP is Investigating Allegations that Ramaco Resources, Inc. (METC) Overstated Development Progress at the Company's Brook Mine
February 18, 2026 13:44 ET | Source: Robbins LLP

Stockholders Who Lost Money Investing in Oracle Corporation Should Contact Robbins LLP for Information About Recovering Their Losses from ORCL

Robbins LLP is Investigating Allegations that Oracle Corporation (ORCL) Misled Investors Regarding its Data Center Capabilities for AI Infrastructure
February 17, 2026 14:29 ET | Source: Robbins LLP

Robbins LLP Urges AGL Stockholders with Large Losses to Contact the Firm for Information About Leading the Agilon Health, Inc. Securities Class Action

Robbins LLP is Investigating Allegations that Agilon Health, Inc. (AGL) Misled Investors Regarding its Business Prospects
February 16, 2026 20:24 ET | Source: Robbins LLP

KD Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Kyndryl Holdings, Inc. Class Action

Robbins LLP is Investigating Allegations that Kyndryl Holdings, Inc. (KD) Materially Misstated its Financial Statements
February 16, 2026 19:42 ET | Source: Robbins LLP

QURE Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the uniQure N.V. Class Action

The Allegations: Robbins LLP is Investigating Allegations that uniQure (QURE) Misled Investors Regarding the Likelihood of FDA Approval of its Drug.
February 13, 2026 14:56 ET | Source: Robbins LLP

INO Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Inovio Pharmaceuticals, Inc. Class Action

Robbins LLP is Investigating Allegations that Inovio Pharmaceuticals, Inc. (INO) Misled Investors Regarding Approval for its CELLECTRA Device
February 13, 2026 13:04 ET | Source: Robbins LLP

FRMI Investors with Large Losses Should Contact Robbins LLP for Information About Leading the Fermi Inc. Class Action

Robbins LLP is Investigating Allegations that Fermi Inc. (FRMI) Misled Investors Regarding its Business Prospects
February 12, 2026 12:14 ET | Source: Robbins LLP

PLUG Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Plug Power Inc. Class Action

Robbins LLP is Investigating Allegations that Plug Power Inc. (PLUG) Misled Investors Regarding its Ability to Receive and Utilize the DOE Loan